Filing Details
- Accession Number:
- 0001181431-14-005577
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-06 17:31:30
- Reporting Period:
- 2014-02-04
- Filing Date:
- 2014-02-06
- Accepted Time:
- 2014-02-06 17:31:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477294 | Sensata Technologies Holding N.v. | ST | Industrial Instruments For Measurement, Display, And Control (3823) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1196701 | J Jeffrey Cote | C/O Sensata Technologies, Inc. 529 Pleasant Street Attleboro MA 02703 | Coo And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value Eur 0.01 Per Share | Acquisiton | 2014-02-04 | 49,420 | $7.30 | 243,358 | No | 4 | M | Direct | |
Ordinary Shares, Par Value Eur 0.01 Per Share | Disposition | 2014-02-04 | 49,420 | $39.50 | 193,938 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value Eur 0.01 Per Share | Stock Options to Buy | Disposition | 2014-02-04 | 49,420 | $0.00 | 49,420 | $7.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-03-28 | No | 4 | M | Direct |
Footnotes
- Includes 162,380 of unvested restricted securities, of which 30,800 securities are subject to performance conditions.
- This transaction was made through a 10B5-1 Sales Plan.
- These options are currently exercisable.